Pharma Sector: Earnings, Specialty Cycles, and Capital Flows The pharmaceutical sector is one of the most globally integrated and structurally defensive segments of the Indian equity market. Indian pharma companies generate a large portion of their revenue from international markets, especially the United States, making the sector highly sensitive to global drug pricing cycles, regulatory … Read more
Indian Pharma Sector Outlook 2026: Defensive Earnings and Global Generics Drive Institutional Flows The pharmaceutical sector enters 2026 with steady global demand, expanding specialty pipelines, and defensive earnings visibility, positioning it as a key institutional allocation during uncertain macro cycles. Indian pharma sector outlook 2026 reflects a balance between defensive earnings stability and long-term growth … Read more
Pharma Sector Outlook 2026: 5 Positive Drivers Powering Exports, Margins, and Specialty Growth Pharma Sector Outlook 2026 indicates a stable-to-positive growth phase driven by export demand, specialty drug pipelines, and improving margins across major pharmaceutical companies. The sector continues to benefit from global healthcare demand, currency tailwinds, and structural shifts toward complex generics and specialty … Read more